Brain Penetrating Bifunctional Erythropoietin–Transferrin Receptor Antibody Fusion Protein for Alzheimer’s Disease-Reference-Cited by-同舟云学术

Brain Penetrating Bifunctional Erythropoietin–Transferrin Receptor Antibody Fusion Protein for Alzheimer’s Disease

Published:2018-09-25 Issue:11 Volume:15 Page:4963-4973
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Chang Rudy¹,Al Maghribi Abrar²,Vanderpoel Victoria³,Vasilevko Vitaly⁴,Cribbs David H.⁴,Boado Ruben⁵,Pardridge William M.⁵^ORCID,Sumbria Rachita K.¹⁴^ORCID

Affiliation:

1. Department of Biopharmaceutical Sciences, School of Pharmacy and Health Sciences, Keck Graduate Institute, Claremont, California 91711, United States

2. Henry E. Riggs School of Applied Life Sciences, Keck Graduate Institute, Claremont, California 91711, United States

3. Department of Neuroscience, Pomona College, Claremont, California 91711, United States

4. Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, California 92697, United States

5. ArmaGen, Inc., Calabasas, California 91302, United States

Funder

National Institute on Aging

Joseph H. Stahlberg Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link